Market Cap 1.70M
Revenue (ttm) 11.51M
Net Income (ttm) -53.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -464.21%
Debt to Equity Ratio -0.70
Volume 48,500
Avg Vol 107,915
Day's Range N/A - N/A
Shares Out 603,000.00
Stochastic %K 68%
Beta -0.11
Analysts Strong Buy
Price Target $16.00

Company Profile

Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. Its lead prescription drug is Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 371 8300
Address:
200 Pine Street, Suite 400, San Francisco, United States
MarketManStockWizzard
MarketManStockWizzard Jul. 4 at 3:12 AM
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 4 at 3:11 AM
$JAGX You can sue the company. Also, expect a halt on trading if SEC investigates. https://share.google/aimode/g3DGlYMahw32CQVOl
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 6:39 PM
$JAGX I warned you a week ago! I was only like 100k shares off. I forgot to add Streeterville 155k last share conversion... but wow! Kinda cool having me here to help out huh?
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 5:24 PM
$JAGX OVER-VALUED BY $14,400,000.00. DANGER OF GHOST EQUITY IN JAGX. JAGX CURRENTLY HAS 4.8m SHARES OUTSTANDING AND TRADING AT $3.X PER SHARE. THIS GIVES US A MKT CAP OF $14,400,000.00. THE COMPANY HAS SHORT TERM DEBT OF $34,000,000.00 GIVING JAGX A VALUATION OF ZER0. WITH ALL THAT GHOST EQUITY CREATED OVER NIGHT BY O SERIES CONVERSION WAS PLANNED TO CONFUSE YOU, BUT CREATED SO THEY HAVE A $14,000,000.00 RUNWAY TO START THE $40,000,000.00 OFFERING WITH. IM TELLING YOU, THEY WILL TAP INTO IT IF YOU DONT.
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 4:33 PM
$JAGX I DONT LIE. $40M WORTH OF SHARES WILL BE SOLD INTO MARKET ANY DAY NOW. S1 WILL BE FILED AND THEN ITS TOO LATE. THESE SHARES WILL BE SOLD AT THE MARKET. THE SELLING AGENT (C/W) WILL BE GETTING THEM AT DISCOUNT AND RE-SELLING THEM ACCORDINGLY.
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 12:20 PM
$JAGX fun fact. The market cap is now 4x more than it was pre split. Ghost equity majic
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 12:08 PM
$JAGX Beautiful teaching moment. LIE # 1 = Jaguar health secured $2M in preferred P series to C/W. Not true. These shares cost NOTHING out of pocket to C/W, in fact it gave C/W an instant $800K in pre funded warrants. Thats the key. The warrants immediately tradable reduce the equity by $800K. This money is now what C/W will start using to place resell orders on the $40M ELOC/ATM Stock sale. Additionally, the P series are the sweetener to protect from downside stock price come christmas time. YES the P series guarantee C/W $2M regardless. Thats why they were able to use the verbage in the public announcement. But in no way is jagx sitting on $2M in cash. All the money comes from YOU, the retail guys getting diluted. Saddle up.
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 10:01 AM
$JAGX GHOST EQUITY. $14,400,000.00 market cap Zero money in the company.
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 9:13 AM
$JAGX hear me out. They will issue a minimum of 13m shares on top of the 4.8m currently outstanding in this offering. Listed a chart for you on my previous posts yesterday. Of course, that number of shares is only if $3.X holds... it will be 26m shares issued At $1.50 or 52m shares issued at $0.75 and so on...
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 8:47 AM
$JAGX RACE TO ZERO!
0 · Reply
Latest News on JAGX
Jaguar Health Transcript: Life Sciences Virtual Investor Forum

Jun 24, 2026, 1:00 PM EDT - 10 days ago

Jaguar Health Transcript: Life Sciences Virtual Investor Forum


Jaguar Health Transcript: Emerging Growth Conference 93

Jun 10, 2026, 12:35 PM EDT - 24 days ago

Jaguar Health Transcript: Emerging Growth Conference 93


Jaguar Health Proxy statement: Proxy filing

May 29, 2026, 8:00 AM EDT - 5 weeks ago

Jaguar Health Proxy statement: Proxy filing


Jaguar Health regains compliance with Nasdaq Listing Rule

2026-05-27T15:43:15.000Z - 5 weeks ago

Jaguar Health regains compliance with Nasdaq Listing Rule


Jaguar Health Compliant with Nasdaq Bid Price Rule

May 27, 2026, 9:00 AM EDT - 5 weeks ago

Jaguar Health Compliant with Nasdaq Bid Price Rule


Jaguar Health Earnings Call Transcript: Q1 2026

May 26, 2026, 8:30 AM EDT - 5 weeks ago

Jaguar Health Earnings Call Transcript: Q1 2026


Jaguar Health Quarterly report: Q1 2026

May 26, 2026, 8:30 AM EDT - 5 weeks ago

Jaguar Health Quarterly report: Q1 2026


Jaguar Health Earnings release: Q1 2026

May 26, 2026, 8:30 AM EDT - 5 weeks ago

Jaguar Health Earnings release: Q1 2026


Jaguar Health Slides: Corporate presentation

May 22, 2026, 7:00 AM EDT - 6 weeks ago

Jaguar Health Slides: Corporate presentation


Jaguar Health reports Q1 EPS ($13.60) vs. ($584.45) last year

2026-05-20T20:50:10.000Z - 6 weeks ago

Jaguar Health reports Q1 EPS ($13.60) vs. ($584.45) last year


Jaguar Health Reports First Quarter 2026 Financials

May 20, 2026, 4:40 PM EDT - 6 weeks ago

Jaguar Health Reports First Quarter 2026 Financials


Jaguar Health Proxy statement: Proxy filing

May 6, 2026, 8:00 AM EDT - 2 months ago

Jaguar Health Proxy statement: Proxy filing


Jaguar Health announces planned launch of Neonorm Dog

2026-05-04T13:09:38.000Z - 2 months ago

Jaguar Health announces planned launch of Neonorm Dog


Jaguar Health Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Jaguar Health Proxy statement: Proxy filing


Jaguar Health announces results from trial of crofelemer

2026-04-29T14:15:11.000Z - 2 months ago

Jaguar Health announces results from trial of crofelemer


Jaguar Health announces 1-for-35 reverse stock split

2026-04-27T13:37:48.000Z - 2 months ago

Jaguar Health announces 1-for-35 reverse stock split


Jaguar Health Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 2 months ago

Jaguar Health Proxy statement: Proxy filing


Jaguar Health Earnings Call Transcript: Q4 2025

Apr 10, 2026, 8:30 AM EDT - 3 months ago

Jaguar Health Earnings Call Transcript: Q4 2025


Jaguar Health Earnings release: Q4 2025

Apr 10, 2026, 8:30 AM EDT - 3 months ago

Jaguar Health Earnings release: Q4 2025


Jaguar Health Annual report: Q4 2025

Apr 10, 2026, 8:30 AM EDT - 3 months ago

Jaguar Health Annual report: Q4 2025


Jaguar Health Reports 2025 Financials

Apr 7, 2026, 8:30 AM EDT - 3 months ago

Jaguar Health Reports 2025 Financials


Jaguar Health Proxy statement: Proxy filing

Mar 24, 2026, 8:00 AM EDT - 3 months ago

Jaguar Health Proxy statement: Proxy filing


Jaguar Health Proxy statement: Proxy Filing

Mar 13, 2026, 8:00 AM EDT - 4 months ago

Jaguar Health Proxy statement: Proxy Filing


Jaguar Health Transcript: Life Sciences Virtual Investor Forum

Mar 12, 2026, 2:00 PM EDT - 4 months ago

Jaguar Health Transcript: Life Sciences Virtual Investor Forum


Jaguar Health Announces a Special One-time Stock Dividend

Feb 18, 2026, 9:00 AM EST - 4 months ago

Jaguar Health Announces a Special One-time Stock Dividend


Jaguar Health Transcript: Emerging Growth Conference 88

Dec 10, 2025, 3:25 PM EST - 7 months ago

Jaguar Health Transcript: Emerging Growth Conference 88


Jaguar Health Slides: Corporate Presentation

Dec 9, 2025, 6:00 PM EST - 7 months ago

Jaguar Health Slides: Corporate Presentation


Jaguar Health Earnings Call Transcript: Q3 2025

Nov 17, 2025, 8:30 AM EST - 8 months ago

Jaguar Health Earnings Call Transcript: Q3 2025


Jaguar Health Earnings release: Q3 2025

Nov 17, 2025, 8:30 AM EST - 8 months ago

Jaguar Health Earnings release: Q3 2025


Jaguar Health Quarterly report: Q3 2025

Nov 17, 2025, 8:30 AM EST - 8 months ago

Jaguar Health Quarterly report: Q3 2025


Jaguar Health Proxy statement: Proxy Filing

Nov 10, 2025, 7:00 AM EST - 8 months ago

Jaguar Health Proxy statement: Proxy Filing


Jaguar Health Proxy statement: Proxy Filing

Oct 28, 2025, 8:00 AM EDT - 8 months ago

Jaguar Health Proxy statement: Proxy Filing


Jaguar Health Registration statement: Registration Filing

Oct 3, 2025, 8:00 AM EDT - 9 months ago

Jaguar Health Registration statement: Registration Filing


Jaguar Health Transcript: Emerging Growth Conference 2025

Sep 25, 2025, 2:55 PM EDT - 10 months ago

Jaguar Health Transcript: Emerging Growth Conference 2025


MarketManStockWizzard
MarketManStockWizzard Jul. 4 at 3:12 AM
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 4 at 3:11 AM
$JAGX You can sue the company. Also, expect a halt on trading if SEC investigates. https://share.google/aimode/g3DGlYMahw32CQVOl
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 6:39 PM
$JAGX I warned you a week ago! I was only like 100k shares off. I forgot to add Streeterville 155k last share conversion... but wow! Kinda cool having me here to help out huh?
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 5:24 PM
$JAGX OVER-VALUED BY $14,400,000.00. DANGER OF GHOST EQUITY IN JAGX. JAGX CURRENTLY HAS 4.8m SHARES OUTSTANDING AND TRADING AT $3.X PER SHARE. THIS GIVES US A MKT CAP OF $14,400,000.00. THE COMPANY HAS SHORT TERM DEBT OF $34,000,000.00 GIVING JAGX A VALUATION OF ZER0. WITH ALL THAT GHOST EQUITY CREATED OVER NIGHT BY O SERIES CONVERSION WAS PLANNED TO CONFUSE YOU, BUT CREATED SO THEY HAVE A $14,000,000.00 RUNWAY TO START THE $40,000,000.00 OFFERING WITH. IM TELLING YOU, THEY WILL TAP INTO IT IF YOU DONT.
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 4:33 PM
$JAGX I DONT LIE. $40M WORTH OF SHARES WILL BE SOLD INTO MARKET ANY DAY NOW. S1 WILL BE FILED AND THEN ITS TOO LATE. THESE SHARES WILL BE SOLD AT THE MARKET. THE SELLING AGENT (C/W) WILL BE GETTING THEM AT DISCOUNT AND RE-SELLING THEM ACCORDINGLY.
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 12:20 PM
$JAGX fun fact. The market cap is now 4x more than it was pre split. Ghost equity majic
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 12:08 PM
$JAGX Beautiful teaching moment. LIE # 1 = Jaguar health secured $2M in preferred P series to C/W. Not true. These shares cost NOTHING out of pocket to C/W, in fact it gave C/W an instant $800K in pre funded warrants. Thats the key. The warrants immediately tradable reduce the equity by $800K. This money is now what C/W will start using to place resell orders on the $40M ELOC/ATM Stock sale. Additionally, the P series are the sweetener to protect from downside stock price come christmas time. YES the P series guarantee C/W $2M regardless. Thats why they were able to use the verbage in the public announcement. But in no way is jagx sitting on $2M in cash. All the money comes from YOU, the retail guys getting diluted. Saddle up.
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 10:01 AM
$JAGX GHOST EQUITY. $14,400,000.00 market cap Zero money in the company.
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 9:13 AM
$JAGX hear me out. They will issue a minimum of 13m shares on top of the 4.8m currently outstanding in this offering. Listed a chart for you on my previous posts yesterday. Of course, that number of shares is only if $3.X holds... it will be 26m shares issued At $1.50 or 52m shares issued at $0.75 and so on...
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 8:47 AM
$JAGX RACE TO ZERO!
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 2 at 8:46 AM
$JAGX well, i was close! Immediately upon completion of the Conversion, there were 4,857,211 shares of Common Stock issued and outstanding, and the holders of the Eligible Warrants are entitled to receive, upon exercise of the Eligible Warrants, up to 839,000 shares of Common Stock, which consist of 68,593 Warrant Shares (as defined in the Eligible Warrants) and 770,407 Conversion Shares. https://jaguarhealth.gcs-web.com/node/16186/html
0 · Reply
focafoca99
focafoca99 Jul. 1 at 8:50 PM
$JAGX executed the conversion of its Series O Preferred Stock into common shares, resulting in about 4.86 million common shares outstanding. https://www.rapidticker.com/news/jagx-sec-filing-2f0003
0 · Reply
The_Gambl3r
The_Gambl3r Jul. 1 at 7:53 PM
1 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 1 at 3:46 PM
$JAGX huge lesson to be learned here. You were afraid to sell. Now you will be forced. Jagx to zero, dont be a hero
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 1 at 1:23 PM
$JAGX go bulls!
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 1 at 1:07 PM
$JAGX HERE WE GO!!
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 1 at 11:03 AM
$JAGX Because the preferred P shares were issued as a dividend with 8% guaranteed return they were able to issue the shares without compensation. The gave away $2,000,000.00 worth of shares and another $160K as an additional gift!! This is headed to $0.
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 1 at 10:57 AM
$JAGX No compensation for the company to cough up $2M worth of preferred P stock to convert and sell to you. Read filing.
0 · Reply
MarketManStockWizzard
MarketManStockWizzard Jul. 1 at 10:45 AM
$JAGX here comes more of the dilution train. Form D relating to series P sweetner preferreds RDO to C/W for downside risk on ELOC offering. Get ready for S1. https://jaguarhealth.gcs-web.com/node/16176/html
1 · Reply
ourscooby
ourscooby Jun. 30 at 5:18 PM
$JAGX Anyone see their series O pfd converted yet?
1 · Reply
JaguarHealthInc
JaguarHealthInc Jun. 30 at 1:35 PM
Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF) https://bit.ly/4vzLCBb $JAGX
0 · Reply
STACKD0E
STACKD0E Jun. 30 at 1:25 PM
0 · Reply